Glyconics, which is part of the Deepbridge Life Sciences EIS portfolio, is one of the final five companies that have been selected for the East of England Investment Catalyst. 

Glyconics, along with the four other companies will receive a final session of coaching to perfect their propositions, before presenting at the Grand Final to an audience of investors in London at the end of this month.

Linn Clabburn, programme director of the Cambridge Norwich Tech Corridor, commented: 

“Congratulations to our five finalists. They embody the kind of innovative, ambitious firms which make East Anglia a fantastic place to do business, and have all worked extremely hard to reach this stage.

“The final is a unique opportunity for them to pitch for investment and build the connections they need to take their companies to the next level.”

To read more, click here.